Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Minister VWS neemt standpunt in over bijbetalen voor niet-preferente geneesmiddelen bij tekort
sep 2024